StockNews.AI
CDLX
StockNews.AI
186 days

Class Action Filed Against Cardlytics, Inc. (CDLX) Seeking Recovery for Investors - Contact Levi & Korsinsky

1. Class action lawsuit filed against Cardlytics for alleged securities fraud. 2. Lawsuit claims false statements about consumer engagement and revenue projections. 3. Investors can participate without upfront costs and may recover losses. 4. Claim period for affected investors is from March to August 2024. 5. Levi & Korsinsky is a reputable firm with extensive litigation experience.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The lawsuit is likely to harm investor confidence, impacting stock price negatively. Similar past cases have led to substantial stock declines for affected companies.

How important is it?

The lawsuit indicates potential fraud affecting investor trust and market perception. Legal issues generally influence stock performance significantly.

Why Short Term?

The immediate legal actions may cause price volatility. Past lawsuits often affect stock performance until resolved.

Related Companies

NEW YORK, Feb. 14, 2025 /PRNewswire/ --

Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.

CLASS DEFINITION:

The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=129230&wire=4

CDLX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS:

The filed complaint alleges that defendants made false statements and/or concealed that: (1) increasing consumer engagement led to an increase in consumer incentives; (2) the Company could not increase its billings commensurate with the increased consumer engagement; (3) as a result, there was a significant risk that its revenue growth would slow or decline; (4) the changes to Ads Decision Engine, which led to increased consumer engagement, led to the "under-delivery" of budgets and customers billing estimates; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT'S NEXT?

If you suffered a loss in Cardlytics during the relevant time frame, you have until March 25, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU:

If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY:

Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE

Levi & Korsinsky, LLP

Related News